Phase II Trial of Weekly Docetaxel and Four Weekly Carboplatin Combination in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer.

Trial Profile

Phase II Trial of Weekly Docetaxel and Four Weekly Carboplatin Combination in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Jul 2010

At a glance

  • Drugs Carboplatin; Docetaxel
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms Carbo-Tax
  • Sponsors Sanofi
  • Most Recent Events

    • 12 Jan 2010 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
    • 12 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Jan 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top